Transaction DateRecipientSharesTypePriceValue
17th September 2020Fuad El Hibri20,000Open or private sale$100.68$2,013,600.00
16th September 2020Fuad El Hibri20,000Open or private sale$102.48$2,049,600.00
10th September 2020Fuad El Hibri20,000Open or private sale$102.66$2,053,200.00
9th September 2020Fuad El Hibri20,000Open or private sale$102.80$2,056,000.00
17th August 2020Zsolt Harsanyi6,609Open or private sale$133.71$883,664.28
21st May 2020Zsolt Harsanyi2,821Grant/award etc.$0.00
14th May 2020Zsolt Harsanyi3,434Exercise of derivative$18.64$64,009.76
11th May 2020Zsolt Harsanyi4,940Open or private sale$81.99$405,024.67
30th April 2020Fuad El Hibri20,000Open or private sale$74.01$1,480,200.00
29th April 2020Fuad El Hibri20,000Open or private sale$74.24$1,484,800.00
Aptevo Therapeutics
Aptevo Therapeutics logo

Aptevo Therapeutics, Inc. was founded on February 22, 2016 and is headquartered in Seattle, WA. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527.

Ticker: APVO
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1671584
Employees: 80
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals